Compare TLF & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLF | ALUR |
|---|---|---|
| Founded | 1980 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 18.9M |
| IPO Year | N/A | N/A |
| Metric | TLF | ALUR |
|---|---|---|
| Price | $2.69 | $1.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 14.0K | ★ 113.9K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | ★ 56.60% | N/A |
| EPS Growth | ★ 308.92 | N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $74,550,000.00 | $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.02 |
| P/E Ratio | $2.26 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.56 | $1.02 |
| 52 Week High | $5.48 | $16.81 |
| Indicator | TLF | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 38.70 |
| Support Level | $2.60 | $1.31 |
| Resistance Level | $2.74 | $1.71 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 31.75 | 17.39 |
Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, Canada and others and generates the highest revenue from the United States.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.